Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review

Date: April 11, 2017
Pages: 48
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SF681247D45EN
Leaflet:

Download PDF Leaflet

Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review
Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with particular focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various cancer types. The company markets its products through direct sales force in the US and through distributors in Europe. Spectrum is headquartered in Henderson, Nevada, the US.

Spectrum Pharmaceuticals Inc Key Recent Developments

Mar 08,2017: Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update
Nov 14,2016: Spectrum Pharmaceuticals Provides Third Quarter Financial Update
Nov 03,2016: Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update
Oct 18,2016: Spectrum Pharmaceuticals Announces Appointment of Luigi Lenaz, M.D., as Lead Director
Aug 09,2016: Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Spectrum Pharmaceuticals Inc - Key Facts
Spectrum Pharmaceuticals Inc - Key Employees
Spectrum Pharmaceuticals Inc - Key Employee Biographies
Spectrum Pharmaceuticals Inc - Major Products and Services
Spectrum Pharmaceuticals Inc - Pharmaceutical Pipeline Products Data
Spectrum Pharmaceuticals Inc, Pipeline Products by Therapy Area
Spectrum Pharmaceuticals Inc, Pipeline Products by Development Phase
Spectrum Pharmaceuticals Inc - History
Spectrum Pharmaceuticals Inc - Company Statement
Spectrum Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Spectrum Pharmaceuticals Inc - Business Description
Spectrum Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Spectrum Pharmaceuticals Inc - Strengths
Spectrum Pharmaceuticals Inc - Weaknesses
Spectrum Pharmaceuticals Inc - Opportunities
Spectrum Pharmaceuticals Inc - Threats
Spectrum Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Spectrum Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 08, 2017: Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update
Nov 14, 2016: Spectrum Pharmaceuticals Provides Third Quarter Financial Update
Nov 03, 2016: Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update
Oct 18, 2016: Spectrum Pharmaceuticals Announces Appointment of Luigi Lenaz, M.D., as Lead Director
Aug 09, 2016: Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update
May 05, 2016: Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
Mar 09, 2016: Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Spectrum Pharmaceuticals Inc, Key Facts
Spectrum Pharmaceuticals Inc, Key Employees
Spectrum Pharmaceuticals Inc, Key Employee Biographies
Spectrum Pharmaceuticals Inc, Major Products and Services
Spectrum Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area
Spectrum Pharmaceuticals Inc, Number of Pipeline Products by Development Stage
Spectrum Pharmaceuticals Inc, History
Spectrum Pharmaceuticals Inc, Other Locations
Spectrum Pharmaceuticals Inc, Subsidiaries
Spectrum Pharmaceuticals Inc, Joint Venture
Spectrum Pharmaceuticals Inc, Key Competitors
Spectrum Pharmaceuticals Inc, Ratios based on current share price
Spectrum Pharmaceuticals Inc, Annual Ratios
Spectrum Pharmaceuticals Inc, Annual Ratios (Cont.1)
Spectrum Pharmaceuticals Inc, Annual Ratios (Cont.2)
Spectrum Pharmaceuticals Inc, Interim Ratios
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Spectrum Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Spectrum Pharmaceuticals Inc, Pipeline Products by Therapy Area
Spectrum Pharmaceuticals Inc, Pipeline Products by Development Phase
Spectrum Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Spectrum Pharmaceuticals Inc, Ratio Charts
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sanofi SA
Pfizer Inc
Novartis Pharmaceuticals Corp
GlaxoSmithKline Plc
Genomic Health Inc
Endo International Plc
Eli Lilly and Company
Celgene Corp
Bristol-Myers Squibb Company
Biogen Inc
Bayer Corp
AstraZeneca Plc
Skip to top


Ask Your Question

Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: